Raj Chovatiya, MD, PhD

Oral JAK inhibitors and Their Use for Treatment of Atopic Dermatitis

Video content above is prompted by the following:

Please review oral JAK inhibitors that are FDA approved for atopic dermatitis (AD) (abrocitinib, upadacitinib).

Are there any differences in the mechanism of action of FDA-approved JAK inhibitors compared with conventional therapies that are important for prescribers to know?

Why is treatment with oral JAK inhibitors an attractive option for AD?

At what point during a patient’s treatment journey would you recommend use of JAK inhibitors?

How does disease severity affect your recommendation?

In which patients would you consider using a JAK inhibitor? Please describe characteristics of an ideal patient for oral JAK inhibitor.

Videos

Medical experts review the FDA-approved oral JAK inhibitors for atopic dermatitis (abrocitinib, upadacitinib), highlighting differences from conventional therapies, their appeal, and the criteria for recommending them based on disease severity and patient characteristics.

JAK Inhibitors and Pathophysiology of Atopic DermatitisAlso covered Q3

Please provide a brief overview of the pathophysiology of atopic dermatitis (AD), a chronic inflammatory condition.

How do JAK inhibitors contribute to the pathophysiology of AD?

After a brief introduction, medical experts review the pathophysiology of atopic dermatitis and explain how JAK inhibitors modulate this inflammatory condition.




JAK Inhibitors and Pathophysiology of Atopic Dermatitis

1:00 The role of photodynamic therapy in the treatment of actinic keratosis

10:40 Refining photodynamic therapy protocols in real world settings

16:21 Setting treatment expectation with your patient with actinic keratosis

19:30 The role of the clinical staff in administrating PDT for actinic keratosis

22:50 Advancements in PDT protocols that have enhanced efficacy of treatment.

27:30 Practical tips for starting PDT in your clinical practice

32:25 Looking ahead into the future of PDT

In this episode of MEDcast, expert dermatologists delve into the practical aspects of using photodynamic therapy (PDT) for treatment of actinic keratosis.  Specialists are sharing their protocols, advances in PDT delivery, tips for training clinical staff and communicating with patients.

Practical Tips for Managing Actinic Keratosis With Photodynamic Therapy in the Clinic

To watch the video series component of this episode, click here.

Raj Chovatiya, MD, PhD

Articles